| MZR | Name: | 5-hydroxy-1-(beta-D-ribofuranosyl)-1H-imidazole-4-carboxamide | Formula: | C9 H13 N3 O6 | SMILES: | O=C(c1ncn(c1O)C2OC(C(O)C2O)CO)N | InChi: | InChI=1S/C9H13N3O6/c10-7(16)4-8(17)12(2-11-4)9-6(15)5(14)3(1-13)18-9/h2-3,5-6,9,13-15,17H,1H2,(H2,10,16)/t3-,5-,6-,9-/m1/s1 | Synonyms: | Mizoribine | Definition date: | 2011-07-12 | Last modified: | 2020-06-17 | Identifier: | 5-hydroxy-1-(beta-D-ribofuranosyl)-1H-imidazole-4-carboxamide |
|
| MZY | Name: | 1,3-dihydroimidazole-2-thione | Formula: | C3 H4 N2 S | SMILES: | S=C1NC=CN1 | InChi: | InChI=1S/C3H4N2S/c6-3-4-1-2-5-3/h1-2H,(H2,4,5,6) | Synonyms: | 2-Mercaptoimidazole | Definition date: | 2016-05-12 | Last modified: | 2020-06-17 | Release date: | 2016-06-01 | Identifier: | 1,3-dihydroimidazole-2-thione |
|
| 9RC | Name: | 5'-O-[(S)-hydroxy(4-nitrophenoxy)phosphoryl]thymidine | Formula: | C16 H18 N3 O10 P | SMILES: | O=C1NC(=O)C(C)=CN1C2CC(O)C(O2)COP(Oc3ccc([N+]([O-])=O)cc3)(=O)O | InChi: | InChI=1S/C16H18N3O10P/c1-9-7-18(16(22)17-15(9)21)14-6-12(20)13(28-14)8-27-30(25,26)29-11-4-2-10(3-5-11)19(23)24/h2-5,7,12-14,20H,6,8H2,1H3,(H,25,26)(H,17,21,22)/t12-,13+,14+/m0/s1 | Synonyms: | PNP-TMP | Definition date: | 2018-06-28 | Last modified: | 2020-06-17 | Release date: | 2019-03-13 | Identifier: | 5'-O-[(S)-hydroxy(4-nitrophenoxy)phosphoryl]thymidine |
|
| N1S | Name: | (2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol | Formula: | C15 H26 O | SMILES: | CC(=CCCC(=CCCC(=C/CO)C)C)C | InChi: | InChI=1S/C15H26O/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-16/h7,9,11,16H,5-6,8,10,12H2,1-4H3/b14-9+,15-11- | Synonyms: | cis,trans-Farnesol | Definition date: | 2019-04-29 | Last modified: | 2020-06-17 | Release date: | 2019-05-08 | Identifier: | (2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol |
|
| 9TG | Name: | 3-[(2R)-2-borono-2-{[(thiophen-2-yl)acetyl]amino}ethyl]benzoic acid | Formula: | C15 H16 B N O5 S | SMILES: | c2c(C(=O)O)cc(CC(B(O)O)NC(=O)Cc1cccs1)cc2 | InChi: | InChI=1S/C15H16BNO5S/c18-14(9-12-5-2-6-23-12)17-13(16(21)22)8-10-3-1-4-11(7-10)15(19)20/h1-7,13,21-22H,8-9H2,(H,17,18)(H,19,20)/t13-/m0/s1 | Synonyms: | boronic acid transition state inhibitor EC04 | Definition date: | 2017-06-07 | Last modified: | 2020-06-17 | Release date: | 2017-11-29 | Identifier: | 3-[(2R)-2-borono-2-{[(thiophen-2-yl)acetyl]amino}ethyl]benzoic acid |
|
| 9TJ | Name: | 3-{1-[(2R)-2-borono-2-{[(thiophen-2-yl)acetyl]amino}ethyl]-1H-1,2,3-triazol-4-yl}benzoic acid | Formula: | C17 H17 B N4 O5 S | SMILES: | C(B(O)O)(Cn2cc(c1cccc(c1)C(O)=O)nn2)NC(=O)Cc3sccc3 | InChi: | InChI=1S/C17H17BN4O5S/c23-16(8-13-5-2-6-28-13)19-15(18(26)27)10-22-9-14(20-21-22)11-3-1-4-12(7-11)17(24)25/h1-7,9,15,26-27H,8,10H2,(H,19,23)(H,24,25)/t15-/m0/s1 | Synonyms: | boronic acid transition state inhibitor S03043 | Definition date: | 2017-06-07 | Last modified: | 2020-06-17 | Release date: | 2017-11-29 | Identifier: | 3-{1-[(2R)-2-borono-2-{[(thiophen-2-yl)acetyl]amino}ethyl]-1H-1,2,3-triazol-4-yl}benzoic acid |
|
| 9TP | Name: | (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol
-5-yl 4,6-O-(thiophen-2-ylmethylidene)-beta-D-glucopyranoside | Formula: | C32 H32 O13 S | SMILES: | O=C1OCC8C1C(c2cc(OC)c(O)c(OC)c2)c4cc3OCOc3cc4C8OC6OC5COC(OC5C(O)C6O)c7sccc7 | InChi: | InChI=1S/C32H32O13S/c1-37-19-6-13(7-20(38-2)25(19)33)23-14-8-17-18(42-12-41-17)9-15(14)28(16-10-39-30(36)24(16)23)44-32-27(35)26(34)29-21(43-32)11-40-31(45-29)22-4-3-5-46-22/h3-9,16,21,23-24,26-29,31-35H,10-12H2,1-2H3/t16-,21+,23+,24-,26+,27+,28+,29+,31+,32-/m0/s1 | Synonyms: | Teniposide | Definition date: | 2013-07-01 | Last modified: | 2020-06-17 | Release date: | 2013-07-24 | Identifier: | (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-(thiophen-2-ylmethylidene)-beta-D-glucopyranoside |
|
| N34 | Name: | N-{3-[1-(3,3-Dimethyl-butyl)-4-hydroxy-2-oxo-1,2,4a,5,6,7-hexahydro-pyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxo-1,2-dihydro
-1lambda6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide | Formula: | C21 H29 N5 O6 S2 | SMILES: | O=S(=O)(Nc1ccc2N=C(NS(=O)(=O)c2c1)C3=C(O)C4N(N(C3=O)CCC(C)(C)C)CCC4)C | InChi: | InChI=1S/C21H29N5O6S2/c1-21(2,3)9-11-26-20(28)17(18(27)15-6-5-10-25(15)26)19-22-14-8-7-13(23-33(4,29)30)12-16(14)34(31,32)24-19/h7-8,12,15,23,27H,5-6,9-11H2,1-4H3,(H,22,24)/t15-/m0/s1 | Synonyms: | N-{3-[(4aS)-1-(3,3-dimethylbutyl)-4-hydroxy-2-oxo-1,2,4a,5,6,7-hexahydropyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxido-2H-1,
2,4-benzothiadiazin-7-yl}methanesulfonamide | Definition date: | 2008-05-01 | Last modified: | 2020-06-17 | Identifier: | N-{3-[(4aS)-1-(3,3-dimethylbutyl)-4-hydroxy-2-oxo-1,2,4a,5,6,7-hexahydropyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide |
|
| N38 | Name: | 3-cyclohexyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-{[3-(4-methoxyphenoxy)propyl]sulfonyl}-L-
alaninamide | Formula: | C26 H41 N3 O7 S | SMILES: | COc3ccc(OCCCS(NC(CC1CCCCC1)C(NC(CO)CC2CCNC2=O)=O)(=O)=O)cc3 | InChi: | InChI=1S/C26H41N3O7S/c1-35-22-8-10-23(11-9-22)36-14-5-15-37(33,34)29-24(16-19-6-3-2-4-7-19)26(32)28-21(18-30)17-20-12-13-27-25(20)31/h8-11,19-21,24,29-30H,2-7,12-18H2,1H3,(H,27,31)(H,28,32)/t20-,21-,24-/m0/s1 | Synonyms: | 3-cyclohexyl-N~2~-{[3-(4-methoxyphenoxy)propyl]sulfonyl}-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alan
inamide (bound form) | Definition date: | 2016-09-12 | Last modified: | 2020-06-17 | Release date: | 2016-11-23 | Identifier: | 3-cyclohexyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-{[3-(4-methoxyphenoxy)propyl]sulfonyl}-L-alaninamide |
|
| N3A | Name: | 2,4-dihydroxy-3-({3-[(2R,4aR,8S,8aR,9R)-9-hydroxy-8-methyl-3-methylidene-7-oxo-1,3,4,7,8,8a-hexahydro-2H-2,4a-ethanonap
hthalen-8-yl]propanoyl}amino)benzoic acid | Formula: | C24 H27 N O7 | SMILES: | O=C(O)c1c(O)c(c(O)cc1)NC(=O)CCC4(C(=O)C=CC32C/C(=C)C(CC2O)CC34)C | InChi: | InChI=1S/C24H27NO7/c1-12-11-24-8-5-17(27)23(2,16(24)9-13(12)10-18(24)28)7-6-19(29)25-20-15(26)4-3-14(21(20)30)22(31)32/h3-5,8,13,16,18,26,28,30H,1,6-7,9-11H2,2H3,(H,25,29)(H,31,32)/t13-,16+,18-,23+,24+/m1/s1 | Synonyms: | Platencin A1 | Definition date: | 2009-06-03 | Last modified: | 2020-06-17 | Identifier: | 2,4-dihydroxy-3-({3-[(2R,4aR,8S,8aR,9R)-9-hydroxy-8-methyl-3-methylidene-7-oxo-1,3,4,7,8,8a-hexahydro-2H-2,4a-ethanonaphthalen-8-yl]propanoyl}amino)benzoic acid |
|
| 9V1 | Name: | 3-[2-[[5-[(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-yl)methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-1~{H}-pyrrol-2-yl]
methyl]-5-[[(3~{R},4~{R})-3-ethyl-4-methyl-5-oxidanylidene-3,4-dihydropyrrol-2-yl]methyl]-4-methyl-1~{H}-pyrrol-3-yl]pro
panoic acid | Formula: | C33 H40 N4 O6 | SMILES: | CC[CH]1[CH](C)C(=O)N=C1Cc2[nH]c(Cc3[nH]c(CC4=NC(=O)C(=C4C)C=C)c(C)c3CCC(O)=O)c(CCC(O)=O)c2C | InChi: | InChI=1S/C33H40N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h8,19-20,34-35H,2,7,9-15H2,1,3-6H3,(H,38,39)(H,40,41)/t19-,20-/m1/s1 | Synonyms: | Billeverdin IXa, bound form | Definition date: | 2017-06-13 | Last modified: | 2020-06-17 | Release date: | 2017-06-21 | Identifier: | 3-[2-[[5-[(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-yl)methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-1~{H}-pyrrol-2-yl]methyl]-5-[[(3~{R},4~{R})-3-ethyl-4-methyl-5-oxidanylidene-3,4-dihydropyrrol-2-yl]methyl]-4-methyl-1~{H}-pyrrol-3-yl]propanoic acid |
|
| 9V5 | Name: | 4-chloranyl-2-nitro-1-(phenylsulfonyl)benzene | Formula: | C12 H8 Cl N O4 S | SMILES: | [O-][N+](=O)c1cc(Cl)ccc1[S](=O)(=O)c2ccccc2 | InChi: | InChI=1S/C12H8ClNO4S/c13-9-6-7-12(11(8-9)14(15)16)19(17,18)10-4-2-1-3-5-10/h1-8H | Synonyms: | BIS-TRIS BUFFER | Definition date: | 2017-07-15 | Last modified: | 2020-06-17 | Release date: | 2017-10-25 | Identifier: | 4-chloranyl-2-nitro-1-(phenylsulfonyl)benzene |
|
| N4P | Name: | N,N-bis(3-aminopropyl)butane-1,4-diamine | Formula: | C10 H26 N4 | SMILES: | NCCCCN(CCCN)CCCN | InChi: | InChI=1S/C10H26N4/c11-5-1-2-8-14(9-3-6-12)10-4-7-13/h1-13H2 | Synonyms: | N4-aminopropylspermidine | Definition date: | 2016-02-26 | Last modified: | 2020-06-17 | Release date: | 2018-08-15 | Identifier: | ~{N}',~{N}'-bis(3-azanylpropyl)butane-1,4-diamine |
|
| N5A | Name: | 5'-N-[(2-AMINO)ETHYL CARBOXAMIDO] ADENOSINE | Formula: | C12 H17 N7 O4 | SMILES: | O=C(NCCN)C3OC(n2cnc1c(ncnc12)N)C(O)C3O | InChi: | InChI=1S/C12H17N7O4/c13-1-2-15-11(22)8-6(20)7(21)12(23-8)19-4-18-5-9(14)16-3-17-10(5)19/h3-4,6-8,12,20-21H,1-2,13H2,(H,15,22)(H2,14,16,17)/t6-,7+,8-,12+/m0/s1 | Synonyms: | (2S,3S,4R,5R)-N-(2-AMINOETHYL)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-CARBOXAMIDE | Definition date: | 2006-06-26 | Last modified: | 2020-06-17 | Identifier: | (2S,3S,4R,5R)-N-(2-aminoethyl)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-carboxamide (non-preferred name) |
|
| N5N | Name: | 2-[[(2S)-4-[[(3S)-1-carbamimidoylpiperidin-3-yl]methylamino]-2-(naphthalen-2-ylsulfonylamino)-4-oxidanylidene-butanoyl]
-cyclopropyl-amino]ethanoic acid | Formula: | C26 H34 N6 O6 S | SMILES: | O=C(O)CN(C(=O)C(NS(=O)(=O)c2cc1ccccc1cc2)CC(=O)NCC3CCCN(C(=[N@H])N)C3)C4CC4 | InChi: | InChI=1S/C26H34N6O6S/c27-26(28)31-11-3-4-17(15-31)14-29-23(33)13-22(25(36)32(16-24(34)35)20-8-9-20)30-39(37,38)21-10-7-18-5-1-2-6-19(18)12-21/h1-2,5-7,10,12,17,20,22,30H,3-4,8-9,11,13-16H2,(H3,27,28)(H,29,33)(H,34,35)/t17-,22-/m0/s1 | Synonyms: | NAPSAGATRAN | Definition date: | 2012-06-11 | Last modified: | 2020-06-17 | Identifier: | N-{[(3S)-1-carbamimidoylpiperidin-3-yl]methyl}-N~2~-(naphthalen-2-ylsulfonyl)-L-asparaginyl-N-cyclopropylglycine |
|
| N5O | Name: | 5'-N-(2-HYDROXYL)ETHYL CARBOXYAMIDO ADENOSINE | Formula: | C12 H16 N6 O5 | SMILES: | O=C(NCCO)C3OC(n2cnc1c(ncnc12)N)C(O)C3O | InChi: | InChI=1S/C12H16N6O5/c13-9-5-10(16-3-15-9)18(4-17-5)12-7(21)6(20)8(23-12)11(22)14-1-2-19/h3-4,6-8,12,19-21H,1-2H2,(H,14,22)(H2,13,15,16)/t6-,7+,8-,12+/m0/s1 | Synonyms: | (2S,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXY-N-(2-HYDROXYETHYL)TETRAHYDROFURAN-2-CARBOXAMIDE | Definition date: | 2006-06-28 | Last modified: | 2020-06-17 | Identifier: | (2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxy-N-(2-hydroxyethyl)tetrahydrofuran-2-carboxamide (non-preferred name) |
|
| N5P | Name: | 1-{2-DEOXY-5-O-[(R)-HYDROXY{[(R)-HYDROXY(PHOSPHONOOXY)PHOSPHORYL]OXY}PHOSPHORYL]-BETA-D-ERYTHRO-PENTOFURANOSYL}-5-NITRO
-1H-INDOLE | Formula: | C13 H17 N2 O14 P3 | SMILES: | [O-][N+](=O)c2cc1ccn(c1cc2)C3OC(C(O)C3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O | InChi: | InChI=1S/C13H17N2O14P3/c16-11-6-13(14-4-3-8-5-9(15(17)18)1-2-10(8)14)27-12(11)7-26-31(22,23)29-32(24,25)28-30(19,20)21/h1-5,11-13,16H,6-7H2,(H,22,23)(H,24,25)(H2,19,20,21)/t11-,12+,13+/m0/s1 | Synonyms: | 5-NITRO-1-INDOLYL-2'-DEOXYRIBOSIDE-5'-TRIPHOSPHATE | Definition date: | 2007-03-21 | Last modified: | 2020-06-17 | Identifier: | 1-{2-deoxy-5-O-[(R)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-erythro-pentofuranosyl}-5-nitro-1H-indole |
|
| 9X1 | Name: | 1,1'-[[1,1'-biphenyl]-4,4'-diylbis(methylene)]bis{4-[(4-chlorophenyl)(methyl)amino]quinolin-1-ium} | Formula: | C46 H38 Cl2 N4 | SMILES: | c1(ccc(Cl)cc1)N(C)c2cc[n+](c3c2cccc3)Cc4ccc(cc4)c8ccc(C[n+]5ccc(c6c5cccc6)N(C)c7ccc(cc7)Cl)cc8 | InChi: | InChI=1S/C46H38Cl2N4/c1-49(39-23-19-37(47)20-24-39)43-27-29-51(45-9-5-3-7-41(43)45)31-33-11-15-35(16-12-33)36-17-13-34(14-18-36)32-52-30-28-44(42-8-4-6-10-46(42)52)50(2)40-25-21-38(48)22-26-40/h3-30H,31-32H2,1-2H3/q+2 | Synonyms: | TCD-717 | Definition date: | 2017-06-21 | Last modified: | 2020-06-17 | Release date: | 2018-02-14 | Identifier: | 1,1'-[[1,1'-biphenyl]-4,4'-diylbis(methylene)]bis{4-[(4-chlorophenyl)(methyl)amino]quinolin-1-ium} |
|
| 9X6 | Name: | thiodiglycolic acid | Formula: | C4 H6 O4 S | SMILES: | O=C(O)CSCC(=O)O | InChi: | InChI=1S/C4H6O4S/c5-3(6)1-9-2-4(7)8/h1-2H2,(H,5,6)(H,7,8) | Synonyms: | 2-(2-hydroxy-2-oxoethylsulfanyl)ethanoic acid | Definition date: | 2013-07-29 | Last modified: | 2020-06-17 | Release date: | 2014-02-26 | Identifier: | 2,2'-sulfanediyldiacetic acid |
|
| 9XX | Name: | (2S)-1-(hexadecanoyloxy)propan-2-yl (10S)-10-methyloctadecanoate | Formula: | C38 H74 O4 | SMILES: | C(CCC(OC(COC(CCCCCCCCCCCCCCC)=O)C)=O)CCCCCC(CCCCCCCC)C | InChi: | InChI=1S/C38H74O4/c1-5-7-9-11-13-14-15-16-17-18-19-24-28-32-37(39)41-34-36(4)42-38(40)33-29-25-21-20-23-27-31-35(3)30-26-22-12-10-8-6-2/h35-36H,5-34H2,1-4H3/t35-,36-/m0/s1 | Synonyms: | (S)-1-(palmitoyloxy)propan-2-yl (S)-10-methyloctadecanoate | Definition date: | 2018-08-29 | Last modified: | 2020-06-17 | Release date: | 2018-11-14 | Identifier: | (2S)-1-(hexadecanoyloxy)propan-2-yl (10S)-10-methyloctadecanoate |
|
| 9XY | Name: | Endoxifen | Formula: | C25 H27 N O2 | SMILES: | CNCCOc1ccc(cc1)C(=C(CC)c2ccccc2)c3ccc(cc3)O | InChi: | InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3/b25-24- | Synonyms: | 4-[(1Z)-1-{4-[2-(methylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl]phenol | Definition date: | 2017-06-26 | Last modified: | 2020-06-17 | Release date: | 2017-10-11 | Identifier: | 4-[(1Z)-1-{4-[2-(methylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl]phenol |
|
| N6P | Name: | 6-(naphthalen-2-yl)-9-(5-O-phosphono-beta-D-ribofuranosyl)-9H-purine | Formula: | C20 H19 N4 O7 P | SMILES: | O=P(O)(O)OCC5OC(n2cnc1c(ncnc12)c4cc3ccccc3cc4)C(O)C5O | InChi: | InChI=1S/C20H19N4O7P/c25-17-14(8-30-32(27,28)29)31-20(18(17)26)24-10-23-16-15(21-9-22-19(16)24)13-6-5-11-3-1-2-4-12(11)7-13/h1-7,9-10,14,17-18,20,25-26H,8H2,(H2,27,28,29)/t14-,17-,18-,20-/m1/s1 | Synonyms: | 6-Naphthylpurine riboside 5'-monophosphate | Definition date: | 2014-03-21 | Last modified: | 2020-06-17 | Release date: | 2014-08-20 | Identifier: | 6-(naphthalen-2-yl)-9-(5-O-phosphono-beta-D-ribofuranosyl)-9H-purine |
|
| 9Y3 | Name: | (2Z)-3-phenylprop-2-enal | Formula: | C9 H8 O | SMILES: | c1cccc(c1)[C@H]=CC=O | InChi: | InChI=1S/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H/b7-4- | Synonyms: | Cis-Cinnamaldehyde | Definition date: | 2018-08-29 | Last modified: | 2020-06-17 | Release date: | 2019-08-14 | Identifier: | (2Z)-3-phenylprop-2-enal |
|
| N6S | Name: | (2S)-N6-(1-Methyl-2-phenylethyl)adenosine-3',5'-cyclic monophosphate | Formula: | C19 H22 N5 O6 P | SMILES: | O=P4(OCC5OC(n2c3ncnc(NC(C)Cc1ccccc1)c3nc2)C(O)C5O4)O | InChi: | InChI=1S/C19H22N5O6P/c1-11(7-12-5-3-2-4-6-12)23-17-14-18(21-9-20-17)24(10-22-14)19-15(25)16-13(29-19)8-28-31(26,27)30-16/h2-6,9-11,13,15-16,19,25H,7-8H2,1H3,(H,26,27)(H,20,21,23)/t11-,13-,15+,16-,19+/m0/s1 | Synonyms: | (2S,4aS,6R,7R,7aR)-6-(6-{[(1S)-1-methyl-2-phenylethyl]amino}-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphi
nine-2,7-diol 2-oxide | Definition date: | 2009-07-08 | Last modified: | 2020-06-17 | Identifier: | (2S,4aS,6R,7R,7aR)-6-(6-{[(1S)-1-methyl-2-phenylethyl]amino}-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide |
|
| 9Z7 | Name: | (3E,7aR,12aS)-3-[(1H-imidazol-4-yl)methylidene]-6,12-dimethoxy-7a-(2-methylbut-3-en-2-yl)-7a,12-dihydro-1H,5H-imidazo[1
',2':1,2]pyrido[2,3-b]indole-2,5(3H)-dione | Formula: | C24 H25 N5 O4 | SMILES: | c15ccccc1C4(C3(NC(C(=C/c2cncn2)N3C(C(=C4)OC)=O)=O)N5OC)C(C)([C@H]=C)C | InChi: | InChI=1S/C24H25N5O4/c1-6-22(2,3)23-12-19(32-4)21(31)28-18(11-15-13-25-14-26-15)20(30)27-24(23,28)29(33-5)17-10-8-7-9-16(17)23/h6-14H,1H2,2-5H3,(H,25,26)(H,27,30)/b18-11+/t23-,24-/m0/s1 | Synonyms: | oxaline | Definition date: | 2017-06-27 | Last modified: | 2020-06-17 | Release date: | 2018-07-04 | Identifier: | (3E,7aR,12aS)-3-[(1H-imidazol-4-yl)methylidene]-6,12-dimethoxy-7a-(2-methylbut-3-en-2-yl)-7a,12-dihydro-1H,5H-imidazo[1',2':1,2]pyrido[2,3-b]indole-2,5(3H)-dione |
|